Document is current

Article History

Received: 12 September 2025

Revised: 31 December 2025

Accepted: 5 March 2026

First Online: 14 March 2026

Declarations

:

: For this type of study formal consent is not required. The study was approved by our Institutional Review Board (Protocol number: 2022P001757).

: Informed consent was obtained from all individual participants included in the study.

: CCT served as a consultant for Boston Scientific, Endoquest Robotics, Enterasense, Enterra Medical, EnVision Endoscopy, Fractyl, Fujifilm, USGI Medical, Medtronic/Covidien, Olympus/Spiration, Xenter and Morphic Medical, on the Board of Directors for Fractyl, has received research grant and support from USGI Medical, Boston Scientific, ERBE, Fractyl, FujiFilm, Olympus/Spiration, Endoquest Robotics, GIE Medical and Morphic Medical, has served as a founder for Bariendo, Enterasense, EnVision Endoscopy and GI Windows, holds ownership interest for GI Windows, EnVision Endoscopy, Enterasense, Fractyl, Bariendo and has received royalty from Endosim. PJ has received research support from Boston Scientific, Cook Medical, Fractyl, Morphic Medical, and USGI Medical, has served as a consultant to Boston Scientific, Cook Medical, ERBE, Fractyl, Morphic Medical, Olympus, Spatz Medical, and USGI Medical, is a co-founder of Bariendo, and has received royalty from Endosim.